Address
Road no. 4, Vatara, Notun Bazar
Dhaka, Bangladesh
Address
Road no. 4, Vatara, Notun Bazar
Dhaka, Bangladesh

Product Name: Olanib Tablet
Brand Name: LYNPARZA
Generic: Olaparib
Indication: Fallopian tube cancer, Ovarian cancer, peritoneal cancer, Pancreatic cancer.
Strength: 150 mg
Each bottle contains: 120 tablets
Olaparib 150 mg tablet (Olanib) is a targeted cancer therapy approved by the FDA. It helps treat ovarian, breast, prostate, and pancreatic cancers linked to certain genetic mutations like BRCA or HRD. By blocking a key protein that cancer cells use to repair themselves, it slows their growth and helps control disease progression.
Avoid using this medication with live vaccines (like yellow fever, varicella, or typhoid) and certain antifungal or antibiotic medications that affect liver enzymes.
Always inform your doctor about all other medicines, supplements, or herbal products before starting treatment.
Before taking Olanib 150 mg tablet, tell your doctor if you have any allergies, heart, liver, kidney, or lung problems.
It should not be used during pregnancy or breastfeeding as it can harm the baby. Both men and women should use effective contraception during and after treatment.
This medicine is not approved for use in children under 12 years of age.
This is a list of common side effects that do not include all.
Olaparib as Olanib 150 mg is available in many countries, but how much it costs depends on local healthcare systems, insurance, and whether a branded or generic product is supplied. In the UK, access is often shaped by NHS or private care arrangements; in India and Bangladesh, quality generics are commonly available and can reduce out-of-pocket expenses; in Turkey’s availability and patient costs vary with hospital procurement and insurance. If affordability is a concern, talk with your oncologist or pharmacist about whether a licensed generic is appropriate for you and how to obtain it safely.
For some conditions, like early breast cancer and specific advanced ovarian cancer cases, treatment is for a defined period, often up to one or two years. For others, such as metastatic breast, prostate, or relapsed ovarian cancers, it can continue until the disease progresses or side effects become intolerable. Your oncologist will determine the exact treatment plan.
Everest Pharmaceuticals Ltd., Bangladesh, manufactures and supplies Olanib (generic version of Olaparib). They supply this medication in those countries where their drug administration approves it.
According to the FDA, olaparib significantly reduced the risk of cancer progression or death in clinical trials for patients with specific gene mutations, such as BRCAm or HRD-positive. For example, in a clinical trial for advanced BRCA-mutated ovarian cancer, it reduced the risk of progression or death by 70%.
Olanib is an oral prescription medication. Take the medication orally twice a day as mentioned in your prescription, with or without food. Dosage and administration can be different depending on the patient’s disease stage or if it has to be administered in combination with other medications. Always consult your doctor before taking any prescription medicine.
It belongs to a class of drugs known as PARP inhibitors. It blocks the PARP enzyme that helps cancer cells repair DNA damage. When the enzyme is blocked, cancer cells can’t repair themselves and eventually die, while healthy cells are less affected.
The effectiveness varies significantly depending on the specific cancer, the stage of the disease, and genetic factors. Clinical trials track how long the drug delays cancer progression, a measure known as progression-free survival (PFS).
Yes. Generic Olaparib (Olanib) is produced by several approved manufacturers in India and Bangladesh. Discuss with your oncologist to confirm if it’s suitable for your treatment.
Disclaimer: Information above is not for use as a medical advice alternative; always consult your doctor before taking any prescription medicines.
Reviews
There are no reviews yet.